No matter what happens with the biosimilar legislation, patent holders will have to go through their patent files carefully. The current generic drug industry was born from the Hatch-Waxman Act of 1984. Among its creations,...
Read MoreThe biotech and pharmaceutical industries face new changes with proposed rules concerning cGMP (current good manufacturing practice) for combination products. The cGMP proposal (74 Fed. Reg. 48,423) by the FDA’s Office of...
Read MoreEven though the pharmaceutical industry has experienced unprecedented growth in recent years, there are many emerging trends that may challenge this. And one of these factors is the growth of emerging markets such as India,...
Read MoreWork can be a stressful place, and in the right kind of stressful environment, it can almost be unbearable, especially if you have a monotonous, sometimes tedious job, where you perform the same repetitive functions over and...
Read MoreWith the health care debate raging in the United States, many experts have already forecasted many possible scenarios for what could be the end result, but are they accurate? As lawmakers continue to wrestle over such issues as...
Read More
Testimonial
Smart Pharmaceutical Consulting has made a major contribution to our manufacturing strategy and how we plan to operate our plant in the future.